PillDexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate
10 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it10 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 2 | SUPPLYING |
| Eugia US LLC | unknown | 2 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
| Somerset Therapeutics, LLC | unknown | 1 | SUPPLYING |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | unknown | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 8, 2019SHORTAGEDrug shortage: Dexamethasone Sodium Phosphate Injection (Eugia US LLC)
Dexamethasone Sodium Phosphate Injection — reported in shortage by Eugia US LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.
- Feb 8, 2019SHORTAGEDrug shortage: Dexamethasone Sodium Phosphate Injection (Somerset Therapeutics, LLC)
Dexamethasone Sodium Phosphate Injection — reported in shortage by Somerset Therapeutics, LLC. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology.